We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.22B
AUM Growth
+$24.1M
Cap. Flow
-$64.8M
Cap. Flow %
-5.33%
Top 10 Hldgs %
43.43%
Holding
146
New
4
Increased
19
Reduced
40
Closed
11

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$2.29M
2
MCHP icon
Microchip Technology
MCHP
+$2.24M
3
DIOD icon
Diodes
DIOD
+$1.56M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.49M
5
CNC icon
Centene
CNC
+$1.41M

Top Sells

Rank Stock Value
1
GD icon
General Dynamics
GD
+$20.3M
2
GNTX icon
Gentex
GNTX
+$7.84M
3
NVDA icon
NVIDIA
NVDA
+$4.77M
4
ORCL icon
Oracle
ORCL
+$4.76M
5
KLAC icon
KLA
KLAC
+$4.51M

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 17.06%
3 Communication Services 12.9%
4 Financials 11.14%
5 Consumer Discretionary 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
26
Zimmer Biomet
ZBH
$18.6B
$13.6M 1.12%
105,480
– –
PFE icon
27
Pfizer
PFE
$144B
$13.1M 1.08%
321,214
+30,448
+10% +$1.32M
NTAP icon
28
NetApp
NTAP
$33.7B
$12.6M 1.04%
197,409
– –
MA icon
29
Mastercard
MA
$496B
$12M 0.98%
32,922
– –
DOX icon
30
Amdocs
DOX
$5.91B
$12M 0.98%
124,539
-1,225
-1% -$113K
CTSH icon
31
Cognizant
CTSH
$24.1B
$11.2M 0.92%
183,423
+3
+0% +$188
GPN icon
32
Global Payments
GPN
$23.5B
$10.9M 0.9%
103,803
– –
MCK icon
33
McKesson
MCK
$102B
$10.6M 0.87%
29,800
-3,206
-10% -$1.16M
AMD icon
34
Advanced Micro Devices
AMD
$745B
$10.5M 0.87%
107,461
– –
MCHP icon
35
Microchip Technology
MCHP
$41.6B
$10.3M 0.85%
123,284
+28,089
+30% +$2.24M
QRVO icon
36
Qorvo
QRVO
$8.02B
$10.2M 0.84%
100,122
– –
CI icon
37
Cigna
CI
$78.9B
$10.1M 0.83%
39,597
-4,488
-10% -$1.31M
GILD icon
38
Gilead Sciences
GILD
$166B
$9.85M 0.81%
118,725
-10,509
-8% -$870K
NVDA icon
39
NVIDIA
NVDA
$4.79T
$9.81M 0.81%
353,110
-220,430
-38% -$4.77M
LMT icon
40
Lockheed Martin
LMT
$134B
$8.24M 0.68%
17,430
– –
REGN icon
41
Regeneron Pharmaceuticals
REGN
$72.1B
$8.05M 0.66%
9,793
– –
CHKP icon
42
Check Point Software Technologies
CHKP
$14.1B
$7.69M 0.63%
59,143
– –
APH icon
43
Amphenol
APH
$176B
$7.61M 0.63%
186,172
– –
STT icon
44
State Street
STT
$49.8B
$7.06M 0.58%
93,320
+8
+0% +$674
CRM icon
45
Salesforce
CRM
$151B
$5.78M 0.48%
28,929
– –
PAYX icon
46
Paychex
PAYX
$42.5B
$5.74M 0.47%
50,119
-1,770
-3% -$201K
INTC icon
47
Intel
INTC
$437B
$5.62M 0.46%
171,931
+3
+0% +$85
BNY
48
Bank of New York Mellon
BNY
$106B
$5.3M 0.44%
116,595
-2,595
-2% -$126K
AIZ icon
49
Assurant
AIZ
$13.9B
$5.11M 0.42%
42,551
-325
-0.8% -$40.7K
DIOD icon
50
Diodes
DIOD
$3.71B
$5.05M 0.42%
54,473
+17,411
+47% +$1.56M
1
2
3 4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Oak Associates held 146 positions worth $1.22B, up 2% from $1.19B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Oak Associates withdrew a net $64.8M in Q1 2023, closing 11 positions and reducing 40 holdings. Its most notable exit was General Dynamics, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Bio-Rad Laboratories Class A worth $2.34M.

  • Oak Associates's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 4,890 shares worth $2.34M.
  • Oak Associates added most to Microchip Technology in Q1 2023, an estimated $2.24M increase.
  • Oak Associates's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $4.77M.
  • Oak Associates fully exited General Dynamics in Q1 2023, selling an estimated $20.3M.
  • Oak Associates's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2023.
  • Oak Associates opened 4 new positions and closed 11 in Q1 2023.
  • Oak Associates's portfolio value rose 2% quarter-over-quarter to $1.22B.

Based on Oak Associates's 13F filing for Q1 2023, filed 11 May 2023.